In contrast, other cancers like bladder cancer and liver hepatocellular carcinoma show instances of heterozygous amplification, potentially correlating with the higher expression levels and the poorer prognosis associated with MATN3 in these conditions. Here, MATN3 is linked to urinary bladder carcinoma.